Resveratrol and its biological actions
DOI:
https://doi.org/10.22377/ijgp.v4i1.113Abstract
Resveratrol is a phytoalexin that is found in a few edible food materials such as grape skins, pea-nuts and red wine. Numerous reports exists in the literature suggesting that dietary resveratrol may act as an antioxidant, promotes nitric oxide production, inhibits platelet aggregation and increases high-density lipoprotein cholesterol, and subsequently may serve as a cardio-protective agent. Recent reports demonstrated that resveratrol can function as a cancer chemopreventive agent, exhibiting anti-inflammatory, neuroprotective, anti-ageing and antiviral properties. However, most of these effects are yet to be confirmed in humans. In the only clinical trial, highdoses of special proprietary formulation has demonstrated blood sugar-lowering effects of resveratrol in type 2 diabetes mellitus.
As with many polyphenols, resveratrol is reasonably well absorbed but has low bioavailability. It is metabolized by hydroxylation, glucuronidation, sulfation and hydrogenation. We reviewed the published literature and reports to consolidate information availableon the biological activity of resveratrol using electronic databases as well as handpicked articles to summarize the biological effects of resveratrol and its clinical benefits against human diseases.
Key words: Resveratrol, chemoprevention, cardio-protection, anti-inflammatory effects
Downloads
References
De la Lastra CA, Villegas I. Resveratrol as an anti-inflammatory
and anti-aging agent: Mechanisms and clinical implications. Mol
Nutr Food Res 2005;49:405-30.
Renaud S, Lorgeril M. Wine, alcohol, platelets, and the French
paradox for coronary heart disease. Lancet 1992;339:1523-6.
Bhat KP, Kosmeder JW, Pezzuto JM. Biological effects of resveratrol.
Antiox Redox Signal 2001;3:1041-64.
Jang M, Cai L, Udenani GO, Slowing KV, Thomas CF, Beecher CW,
et al. Cancer chemopreventive activity of resveratrol, a natural
product derived from grapes. Science 1997;275:218-20.
Prokop J, Abrman P, Seligson AL, Sovak M. Resveratrol and its
glycon piceid are stable polyphenols. J Med Food 2006;9:11-4.
Ray PS, Maulik G, Cordis GA., Bertelli AA, Bertelli A, Das DK. The
red wine antioxidant resveratrol protects isolated rat hearts from
ischemia reperfusion injury. Free Rad Biol Med 1999;27:160-9.
Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic
compound, on reactive oxygen species and prostaglandin
production. Biochem. Pharmacol 2000;59:865-70.
Leonard S, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK,
et al. Resveratrol scavenges reactive oxygen species and effects
radical-induced cellular responses. Biochem Biophys Res Commun
;309:1017-26.
Yen GC, Duh PD, Lin CW. Effects of resveratrol and 4-hexylresorcicol
on hydrogen peroxide-induced oxidative DNA damage in human
lymphocytes. Free Radic Res 2003;37: 509-14.
Hattori R, Otani H, Maulik N, Das DK. Pharmacological
preconditioning with resveratrol. Role of nitric oxide. Am J Physiol
Heart Circ Physiol 2002;282:1988-95.
Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial
ischemia-reperfusion injury through both NO-dependent and
NO- independent mechanisms. Free Radic Biol Med 2004;36:774- 81.
Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. Effects of red wine
and wine polyphenol resveratrol on platelet aggregation in vivo
and in vitro. Int J Mol Med 2002;9: 77-9.
Olas B, Wachowicz B, Bald E, Glowacki R. The protective effects
of resveratrol against changes in blood platelet thiols induced by
platinum compounds. J Physiol Pharmacol 2004;5:467-76.
Rimando AM, Nagmani R, Feller DR, Yokoyama W. Pterostilbene,
a new agonist for the peroxisome proliferator-activated
receptor alpha-isoform, lowers plasma lipoproteins and
cholesterol in hypercholesterolemic hamsters. J Agric Food Chem
;53:3403- 07.
Bradamante S, Barenghi L, Villa A. Cardiovascular protective
effects of Resveratrol. Cardiovascul Drug Rev 2006;22:169-88.
Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H,
Sakata T, et al. Resveratrol, a red wine constituent polyphenol,
prevents superoxide-dependent inflammatory responses induced
by ischemia/reperfusion, platelet-activating factor, or oxidants.
Free Radic Biol Med 2003;34:810-17.
Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ. Resveratrol
suppresses nuclear factor-kappaB in herpes simplex virus infected
cells. Antiviral Res 2006;72:242-51.
Palamara AT, Nencioini L, Aquilano K, de Chiara G, Hernandez L,
Cozzolino F, et al. Inhibition of influenza A virus replication by
resveratrol. J Infect Dis 2005;191:1719-29.
Savouret JF, Quesne M. Resveratrol and Cancer: A review. Biomed
Pharmacother 2002;56:84-7.
Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT,
Young HA, et al. Inhibition of prostate cancer growth by muscadine
grape skin extract and resveratrol through distinct mechanisms.
Cancer Res 2007;67:8396-405.
Shankar S, Singh G, Srivastava RK. Chemoprevention by
resveratrol: Molecular mechanisms and therapeutic potential.
Front Biosci 2007;12:4839-54.
Kundu JK, Surh YJ. Cancer chemopreventive and Therapeutic
potential of resveratrol: Mechanistic Perspectives. Cancer Lett
;269:243-61.
Winker MA, Flanagin A, Chi-Lum B, White J, Andrews K,
Kennett RL, et al. Guidelines for medical and health information
sites on the Internet: Principles governing AMA web sites. JAMA
;283:1600-6.
Wootton J. Directory of databases. The Vienna International
Academy For Integrated medicine. The Rosenthal center for
Complementary and Alternative medicine. 2004; Available from:
Http://cpmcnet.columbia.edu/dept/rosenthal/Databases.html.
Eysenback G, Diepgen TL. Towards quality management of
medical information on the internet. Evaluation, labeling and
filtering of information. Br Med J 1998;317:1496-502.
Silberg WM, Lunberg GD, Musacchio RA. Assessing, controlling
and assuming the quality of medical information on the Internet.
Caveant lector et viewer- let the reader and viewer beware. JAMA
;277:1244-5.
Garvin S, Öllinger K, Dabrosin C. Resveratrol induces apoptosis
and inhibits angiogenesis in human breast cancer xenografts
in vivo. Cancer Lett 2006;231:113-22.
Zhiqiang P, Ameeta KA, Tao X, Qin F, Scott RB, Stephen OD, et al.
Identification of molecular pathways affected by pterostilbene,
a natural dimethylether analog of resveratrol. Med Genomics
;1:7.
Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA.
Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1
adipocytes. Phytother Res 2008;22:1367-71.
Jang M, Pezzuto JM. Cancer chemo-preventive activity of
resveratrol. Drug Exp Clin Res 1999;25:65-77.
Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The
in vivo evidence. Nat Rev Drug Discov 2006;5:493-06.
Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T,
Delaisse JM. Resveratrol inhibits myeloma cell growth, prevents
osteoclast formation, and promotes osteoblast differentiation.
Cancer Res 2005;65:9943-52.
Aggarwal BB, Bharadwaj A, Aggarwal RS, Seeram NP, Shishodia S,
Takada Y. Role of resveratrol in prevention and therapy of cancer:
Preclinical and clinical studies. Anticancer Res 2004;24:2783-840.
Gusman J, Malonne H, Atassi G. A reappraisal of the potential
chemopreventive and chemotherapeutic properties of resveratrol.
Carcinogenesis 2001;22:1111-7.
Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA,
Ducharme MP, et al. Phase I dose escalation pharmacokinetic
study in healthy volunteers of resveratrol, a potential cancer
chemopreventive agent. Cancer Epidemiol Biomarkers Prev
;16:1246-52.
Buluc M, Ayaz M, Turan B, Demirel-Yilmaz E. Resveratrol-induced
depression of the mechanical and electrical activities of the rat heart
is reversed by glyburide: Evidence for possible K (ATP) channels
activation. Arch Pharm Res 2007;30:603-7.
Wang GY, Song CM, Zhang LN, Li Q, Yue H, Feng JK, et al. Roles of
potassium channel in effects of resveratrol on isolated myocardial
contractility and heart rate research in guinea pig. Zhongguo
Zhong Yao Za Zhi 2007;32:1317-9.
Floreani M, Napoli E, Quintieri L, Palatini P. Oral administration
of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase
and catalase activities and protects isolated atria from menadione
toxicity. Life Sci 2003;72:2741-50.
Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S,
et al. Resveratrol increases vascular oxidative stress resistance.
Am J Physiol Heart Circ Physiol 2007;292:2417-24.
El-Mowafy AM, White RE. Resveratrol inhibits MAPK activity and
nuclear translocation in coronary artery smooth muscle: Reversal
of endothelin-1 stimulatory effects. FEBS Lett 1999;45:63-7.
Das DK, Maulik N. Resveratrol in cardioprotection: Therapeutic
promise of alternative medicine. Molecular Interventions
;6:36-47.
Pendurthi UR, Williams JT, Rao LV. Resveratrol, a polyphenolic
compound found in wine, inhibits tissue factor expression in
vascular cells: A possible mechanism for the cardiovascular
benefits associated with moderate consumption of wine.
Arterioscler Throm Vasc Biol 1999;19:419-26.
Yu HP, Hsu JC, Hwang TL, Yen CH, Lau YT. Resveratrol attenuates
hepatic injury after trauma-hemorrhage via estrogen receptorrelated
pathway. Shock 2008;30:324-8.
Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de
Gaetano G, et al. Effects of trans-resveratrol, a natural polyphenolic
compound, on human polymorphonuclear leukocyte function. Br J
Pharmacol 1998;123:1691-9.
Baxter RA. Anti-aging properties of resveratrol: Review and
report of a potent new antioxidant skin care formulation. J Cosmet
Dermatol 2008;7:2-7.
Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective
effect of resveratrol, a natural antioxidant derived from grapes.
Cardiovasc. Res 2000;47:549-55.
Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C,
Catoire H, et al. Resveratrol rescues mutant polyglutamine
cytotoxicity in C. elegans and mammalian neurons. Nature Genetics
;4:349-50.
Wallerath T, Deckert G, Temes T, Abnderson H, Li H, Witte K,
et al. Resveratrol, a polyphenolic phytoalexin present in red
wine, enhances expression and activity of endothelial nitric oxide
synthase. Circulation 2002;106:1652-8.
Pitzpatrick DF, Hirschfield SL, Coffey RG. Endotheliumdependent
vasorelaxing activity of wine or other grape products.
Am. J Physiol 1993;265:748-77.
Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK.
Pharmacologic preconditioning with resveratrol. An insight with
iNOS knockout mice. Am J Physiol 2002; 282:1996-03.
Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM.
The red wine phenolics trans-resveratrol and quercetin block
human platelet aggregation and eicosanoid synthesis: Implications
for protection against coronary heart disease. Clin Chim Acta 1995;
:207-19.
Yang YM, Chen JZ, Wang XX, Wang SJ, Hu H, Wang HQ.
Resveratrol attenuates thromboxane A2 receptor agonist-induced
platelet activation by reducing phospholipase C activity. Eur J
Pharmacol 2008;583:148-55.
Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S,
Wood JG, et al. Small molecule activators of sirtuins extend
Saccharomyces cerevisiae lifespan. Nature 2003; 425:191-6.
Wood JG, Rogina B, Lavu1 S, Howitz K, Helfand SL, Tatar M,
et al. Sirtuin activators mimic caloric restriction and delay aging
in metazoans. Nature 2004;430:686-9.
Gruber J, Tang SY, Halliwell B. Evidence for a trade-off
between survival and fitness caused by resveratrol treatment of
Caenorhabditis elegans. Ann N Y Acad Sci 2007;1100:530-42.
Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L.
Effects of resveratrol on life span in Drosophila melanogaster and
Caenorhabditis elegans. Mech Ageing Dev 2007;128:546-52.
Valenzano DR, Terzibasi E, Genade T, Cattageo A, Domenici L,
Cellerino A. Resveratrol prolongs lifespan and retards the onset
of age related markers in a short-lived vertebrate. Curr Biol
;16:296-300.
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A,
et al. Resveratrol improves health and survival of mice on a highcalorie
diet. Nature 2006;444:337-42.
Szkudelski T. The insulin-suppressive effect of resveratrol - An
in vitro and in vivo phenomenon. Life Sci 2008;82:430-5.
Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its
combination with resveratrol or curcumin in attenuation of
diabetic neuropathic pain: Participation of nitric oxide and
TNF- alpha. Phytother Res 2007;21:278-83.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C,
Daussin F, et al. Resveratrol improves mitochondrial function and
protects against metabolic disease by activating SIRT1 and PGC-
alpha. Cell 2006;127:1109-22.
Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, et al.
Trans- resveratrol relaxes the corpus cavernosum ex vivo and
enhances testosterone levels and sperm quality in vivo. Arch Pharm
Res 2008;31:83-7.
Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventos R, Cherubini A,
Jauregui O, de la Torre R, et al. HPLC-tandem mass spectrometric
method to characterize resveratrol metabolism in humans. Clin
Chem 2007;53:292-9.
Chow HHS, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, et al.
Phase I pharmacokinetic study of tea polyphenols following singledose
administration of epigallocatechin gallate and polyphenon E.
Cancer Epidemiol Biomarkers Prev 2001; 10:53-8.
Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High
absorption but very low bioavailability of oral resveratrol in
humans. Drug Metab Dispos 2004;32:1377-82.
Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP.
Metabolism and disposition of resveratrol in rats: Extent of
absorption, glucuronidation, and enterohepatic recirculation
evidenced by a linked-rat model. J Pharmacol Exp Ther 2002;
:369-73.
Gehm BD, McAndrews JM, Chien P, Jameson JL. Resveratrol, a
polyphenolic compound found in grapes and wine, is an agonist
for the estrogen receptor. Proc Nat Acad Sci 1997;94:14138-43.
Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol
acts as a mixed agonist/antagonist for estrogen receptors alpha
and beta. Endocrinol 2000;141:3657-67.
www.biospace.com. Sirtris pharmaceuticals (SIRT) Announces
SRT501 Lowers glucose in twice daily dosing clinical trial;
Study Suggests Dose Response for Proprietary Formulation of
Resveratrol in Type 2 Diabetics [last accessed on 2008 Apr 17].
